Presenter: Elizabeth Ciemans, PhD, MPH, MA, Senior VP Research and Analytics at AMGA
The current quality performance measure for colorectal cancer (CRC) screening is limited to initial screening. Despite low rates, there is no measure for appropriate follow-up with colonoscopy after receipt of an abnormal result of a stool-based screening test (SBT) for CRC. A quality performance measure is needed. Dr. Ciemans is leading the charge on developing a measure. Learn how you can help contribute to this measure and become an early adopter!